A polarized country isn’t a recipe for positive change regarding the healthcare sector. Money will still be made, but this won’t necessarily benefit public health.

THE ECONOMIST: It’s time to watch the interplay between Donald Trump, technology and radical uncertainty.

Six influential AI papers from January to June

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and vaccines from France's Sanofi at the start of 2025, according to data analyzed by healthcare research firm 3 Axis Advisors.

A handful of studies in the past year have found that following a plant-based diet, staying active during the day and doing weekly strength training could help slow the aging process.

Battle of the AI giants

If your New Year's resolution is to drink less alcohol, Life Kit is here to help. Sign up for our Dry January newsletter series, and get tips and strategies to help you stay alcohol-free for a month.

Please review the available slots below and click on the button to sign up. Thank you!

Discover 100 collaborative articles on domains such as Marketing, Public Administration, and Healthcare. Our expertly curated collection combines AI-generated content with insights and advice from ind...